Literature DB >> 18690134

Variation in DVT prophylaxis for adolescent trauma patients: a survey of the Society of Trauma Nurses.

Sarah H O'Brien1, Kathy Haley, Kelly J Kelleher, Wei Wang, Christine McKenna, Barbara A Gaines.   

Abstract

We performed a survey of the Society of Trauma Nurses to explore current practice patterns for deep venous thrombosis prophylaxis in adolescent trauma patients and analyzed responses from 133 institutions. The majority of adult prophylaxis protocols include older adolescents. Only 41% of adult programs identified patient age as "very" important in prophylaxis decision making. Pelvic fracture, spinal cord injury, and expected immobilization were rated most important. Pharmacologic prophylaxis in 11- to 15-year-olds was infrequent, with 60% of centers using never or rarely. Use was much higher but variable among older adolescents. No consensus on deep venous thrombosis prophylaxis in adolescent trauma emerged from our survey.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690134     DOI: 10.1097/01.JTN.0000327327.83276.87

Source DB:  PubMed          Journal:  J Trauma Nurs        ISSN: 1078-7496            Impact factor:   1.010


  3 in total

1.  A multinational study of thromboprophylaxis practice in critically ill children.

Authors:  Edward Vincent S Faustino; Sheila Hanson; Philip C Spinella; Marisa Tucci; Sarah H O'Brien; Antonio Rodriguez Nunez; Michael Yung; Edward Truemper; Li Qin; Simon Li; Kimberly Marohn; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

2.  Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases.

Authors:  Bhuvana A Setty; Sarah H O'Brien; Bryce A Kerlin
Journal:  Pediatr Blood Cancer       Date:  2011-10-28       Impact factor: 3.167

3.  Survey of pharmacologic thromboprophylaxis in critically ill children.

Authors:  Edward Vincent S Faustino; Sonya Patel; Ravi R Thiagarajan; Deborah J Cook; Veronika Northrup; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.